Literature DB >> 3338364

Does healing of esophagitis improve esophageal motor function?

V F Eckardt1.   

Abstract

This study investigates whether healing of erosive esophagitis leads to an improvement of esophageal motor abnormalities. Manometric studies were performed in 18 patients with erosive esophagitis before and after healing of the mucosal lesions and in 15 healthy controls. Nine patients were treated with a Nissen fundoplication and nine with H2-receptor antagonists. After healing, patients were followed for a mean duration of 3.0 +/- 0.4 years. Compared to controls, patients had significantly lower contraction amplitudes and lower esophageal sphincter pressures (P less than 0.01), while the duration and velocity of esophageal contractions was similar in both groups. Lower esophageal sphincter pressure increased after surgical treatment, while no such changes were observed in medically treated patients. In both groups amplitude, duration, and velocity of esophageal contractions were not affected by healing of esophagitis. On extended follow-up, all surgically treated patients remained asymptomatic while eight of nine medically treated patients developed a symptomatic relapse which was accompanied by erosive esophagitis in six of them. The lack of improvement in esophageal motor function after healing of esophagitis may contribute to the frequent occurrence of relapse in medically treated patients.

Entities:  

Mesh:

Year:  1988        PMID: 3338364     DOI: 10.1007/bf01535727

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Relation of gastroesophageal reflux to yield sphincter pressures.

Authors:  J K Haddad
Journal:  Gastroenterology       Date:  1970-02       Impact factor: 22.682

2.  Esophageal emptying and acid neutralization in patients with symptoms of esophageal reflux.

Authors:  M K Ferguson; J W Ryan; A G Little; D B Skinner
Journal:  Ann Surg       Date:  1985-06       Impact factor: 12.969

3.  [Gastro-esophageal reflux: is there a correlation between the degree of reflux and its effects?].

Authors:  H F Weiser; A Hölscher; J R Siewert
Journal:  Dtsch Med Wochenschr       Date:  1983-06-17       Impact factor: 0.628

4.  Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects.

Authors:  J Dent; W J Dodds; R H Friedman; T Sekiguchi; W J Hogan; R C Arndorfer; D J Petrie
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

5.  Experimental esophagitis in cats impairs lower esophageal sphincter pressure.

Authors:  G L Eastwood; D O Castell; R H Higgs
Journal:  Gastroenterology       Date:  1975-07       Impact factor: 22.682

6.  Oesophageal acid clearing: one factor in the production of reflux oesophagitis.

Authors:  C Stanciu; J R Bennett
Journal:  Gut       Date:  1974-11       Impact factor: 23.059

7.  Gastric emptying in patients with gastroesophageal reflux.

Authors:  R W McCallum; D M Berkowitz; E Lerner
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

8.  Does surgery correct esophageal motor dysfunction in gastroesophageal reflux.

Authors:  C O Russell; C E Pope; R M Gannan; F D Allen; N Velasco; L D Hill
Journal:  Ann Surg       Date:  1981-09       Impact factor: 12.969

9.  Clinical and manometric findings in benign peptic strictures of the esophagus.

Authors:  G Ahtaridis; W J Snape; S Cohen
Journal:  Dig Dis Sci       Date:  1979-11       Impact factor: 3.199

10.  Pathogenesis of esophagitis in patients with gastroesophageal reflux.

Authors:  A G Little; T R DeMeester; P T Kirchner; G C O'Sullivan; D B Skinner
Journal:  Surgery       Date:  1980-07       Impact factor: 3.982

View more
  25 in total

1.  Outcome of laparoscopic Nissen fundoplication in patients with disordered preoperative peristalsis.

Authors:  R J Baigrie; D I Watson; J C Myers; G G Jamieson
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Clinical outcomes after laparoscopic antireflux surgery in patients with and without preoperative endoscopic esophagitis.

Authors:  Ketan M Desai; Margaret M Frisella; Nathaniel J Soper
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

Review 3.  Reflux vomiting.

Authors:  P J Milla
Journal:  Arch Dis Child       Date:  1990-09       Impact factor: 3.791

4.  Ineffective esophageal motility is a primary motility disorder in gastroesophageal reflux disease.

Authors:  Shih-Chi Ho; Chi-Sen Chang; Chun-Ying Wu; Gran-Hum Chen
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

5.  Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease.

Authors:  G J Wetscher; M Gadenstaetter; P J Klingler; H Weiss; P Obrist; H Wykypiel; A Klaus; C Profanter
Journal:  Ann Surg       Date:  2001-11       Impact factor: 12.969

6.  Refundoplication for recurrent gastroesophageal reflux.

Authors:  M E Luostarinen; J O Isolauri; M O Koskinen; J O Laitinen; M J Matikainen; T S Lindholm
Journal:  World J Surg       Date:  1993 Sep-Oct       Impact factor: 3.352

7.  [Antireflux therapy--more than acid reduction?].

Authors:  T Frieling
Journal:  Internist (Berl)       Date:  2004-12       Impact factor: 0.743

Review 8.  The Nissen fundoplication: indication, technical aspects and postoperative outcome.

Authors:  H Wykypiel; G J Wetscher; P Klingler; K Glaser
Journal:  Langenbecks Arch Surg       Date:  2004-09-04       Impact factor: 3.445

9.  Selection of patients with gastroesophageal reflux disease for antireflux surgery based on esophageal manometry.

Authors:  Alexander Klaus; Michael Gadenstaetter; Gilbert Mühlmann; Werner Kirchmayr; Christoph Profanter; Sami R Achem; Gerold J Wetscher
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

10.  Laparoscopic Toupet fundoplication for gastroesophageal reflux disease with poor esophageal body motility.

Authors:  R J Lund; G J Wetcher; F Raiser; K Glaser; G Perdikis; M Gadenstätter; N Katada; C J Filipi; R A Hinder
Journal:  J Gastrointest Surg       Date:  1997 Jul-Aug       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.